Compound
US8394825B2 · kind B2 · utility
7Cited by
2References
48Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 27, 2008 |
| Grant date | Mar 12, 2013 |
| Priority date | — |
| Expiry date | May 19, 2029 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention involves tetrahydroisoquinoline compounds and their use in the inhibition and/or prevention of tumor growth.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.